Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verheijen

Showing results (211-220 of 1,091) with videos related to

Pageof 110
Sort By:
Regulatory Toxicology and Pharmacology : RTP|February 23, 2020
Towards the development of an omics data analysis frameworkMarcha Verheijen, Weida Tong, Leming Shi, et al.
Nanotechnology|February 14, 2015
Sub-nanometer dimensions control of core/shell nanoparticles prepared by atomic layer depositionM J Weber, M A Verheijen, A A Bol, et al.
Ecology and Evolution|September 11, 2023
Lesser Prairie-chicken incubation behavior and nest success most influenced by nest vegetation structureJacquelyn M Gehrt, Daniel S Sullins, Bram H F Verheijen, et al.
Journal of Human Evolution|December 24, 2022
Early evidence for bear exploitation during MIS 9 from the site of Schöningen 12 (Germany)Ivo Verheijen, Britt M Starkovich, Jordi Serangeli, et al.
Seminars in Cancer Biology|April 15, 1999
CA 125: fundamental and clinical aspectsR H Verheijen, S von Mensdorff-Pouilly, G J van Kamp, et al.
Pharmaceutical Research|April 17, 2001
Inhibition of angiotensin II-induced inositol phosphate production by triacid nonpeptide antagonists in CHO cells expressing human AT1 receptorsP M Vanderheyden, I Verheijen, F L Fierens, et al.
Biochimica Et Biophysica Acta|September 28, 1984
Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned mediumE D Sprengers, J H Verheijen, V W Van Hinsbergh, et al.
Thrombosis and Haemostasis|December 29, 1984
Fibrinolytic activators and inhibitors in terminal renal insufficiency and in anephric patientsE J Brommer, I Schicht, G Wijngaards, et al.
Thrombosis Research|October 1, 1983
Differences in effects of fibrin(ogen) fragments on the activation of 1-glu-plasminogen and 442-val-plasminogen by tissue-type plasminogen activatorJ H Verheijen, W Nieuwenhuizen, D W Traas, et al.
Developmental Neuroscience|January 1, 1991
Sialic acid storage disorders: observations on clinical and biochemical variationG M Mancini, F W Verheijen, C E Beerens, et al.
Pageof 110

Showing results (211-220 of 1,091) with videos related to

Sort By:
Pageof 110
Regulatory Toxicology and Pharmacology : RTP|February 23, 2020
Towards the development of an omics data analysis frameworkMarcha Verheijen, Weida Tong, Leming Shi, et al.
Nanotechnology|February 14, 2015
Sub-nanometer dimensions control of core/shell nanoparticles prepared by atomic layer depositionM J Weber, M A Verheijen, A A Bol, et al.
Ecology and Evolution|September 11, 2023
Lesser Prairie-chicken incubation behavior and nest success most influenced by nest vegetation structureJacquelyn M Gehrt, Daniel S Sullins, Bram H F Verheijen, et al.
Journal of Human Evolution|December 24, 2022
Early evidence for bear exploitation during MIS 9 from the site of Schöningen 12 (Germany)Ivo Verheijen, Britt M Starkovich, Jordi Serangeli, et al.
Seminars in Cancer Biology|April 15, 1999
CA 125: fundamental and clinical aspectsR H Verheijen, S von Mensdorff-Pouilly, G J van Kamp, et al.
Pharmaceutical Research|April 17, 2001
Inhibition of angiotensin II-induced inositol phosphate production by triacid nonpeptide antagonists in CHO cells expressing human AT1 receptorsP M Vanderheyden, I Verheijen, F L Fierens, et al.
Biochimica Et Biophysica Acta|September 28, 1984
Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned mediumE D Sprengers, J H Verheijen, V W Van Hinsbergh, et al.
Thrombosis and Haemostasis|December 29, 1984
Fibrinolytic activators and inhibitors in terminal renal insufficiency and in anephric patientsE J Brommer, I Schicht, G Wijngaards, et al.
Thrombosis Research|October 1, 1983
Differences in effects of fibrin(ogen) fragments on the activation of 1-glu-plasminogen and 442-val-plasminogen by tissue-type plasminogen activatorJ H Verheijen, W Nieuwenhuizen, D W Traas, et al.
Developmental Neuroscience|January 1, 1991
Sialic acid storage disorders: observations on clinical and biochemical variationG M Mancini, F W Verheijen, C E Beerens, et al.
Pageof 110